Al-Sakkaf A.M., Bonfill X., Ardiles-Ruesjas S., Bendersky-Kohan J., Sola I., Masia J.. Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review. Journal of Plastic Reconstructive and Aesthetic Surgery. 2023; 84DOI:10.1016/j.bjps.2023.05.002. PMID:37329747. IF:2.000(Q2/4D).

Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.. JCO Precision Oncology. 2023; 7DOI:10.1200/PO.22.00258. PMID:36716415. IF:5.300(Q1/2D).

Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).

González-Sánchez C., Salvador-Egea M.P., Glückmann-Maldonado E., Ríos A., Martín-Fernández J., Pérez-García J.I., García-Lorenzo F., Flores-Pastor B., Gómez-Ramírez J., Ortega-Serrano J., Ros-López S., Villar-del-Moral J., Morales-García D., Gutiérrez-Rodríguez M.T., Domènech-Calvet J., Nuño-Vázquez-Garza J.M., Franch-Arcas G.. Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02945-x. PMID:37221304. IF:2.100(Q2/4D).

Ortiz, A, Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. NEFROLOGIA. 2023; 43(1)DOI:10.1016/j.nefro.2022.07.002. PMID:37217372. IF:2.000(Q2/5D).

Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).

Salazar J., Bracchiglione J., Acosta-Dighero R., Meza N., Meade A.-G., Quintana M.J., Requeijo C., Rodríguez-Grijalva G., Santero M., Selva A., Solà I., Bonfill X., Salas K., Antequera A., Auladell-Rispau A., Urrútia G., Meinardi P., Irassar J., Simancas D., Dorantes R., Merchán A., Cantero Y., Hernandez E., Sugrañes M.. Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. SUPPORTIVE CARE IN CANCER. 2023; 31(2)DOI:10.1007/s00520-022-07564-8. PMID:36622453. IF:2.800(Q1/1D).

Sala, R, Rioja-Blanco, E, Serna, N, Sanchez-Garcia, L, Alamo, P, Alba-Castellon, L, Casanova, I, Lopez-Pousa, A, Unzueta, U, Cespedes, MV, Vazquez, E, Villaverde, A, Mangues, R. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. DRUG DELIVERY. 2022; 29(1)DOI:10.1080/10717544.2022.2069302. PMID:35532120. IF:6.000(Q1/2D).